Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Xeroderma Pigmentosum”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)UnknownNCT00002811
What this trial is testing

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

Who this might be right for
Precancerous Condition
Applied Genetics 30
Not applicableStudy completedNCT00025012
What this trial is testing

Isotretinoin in Preventing Skin Cancer

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not applicableEnrolling By InvitationNCT06330324
What this trial is testing

Reproductive Options in Inherited Skin Diseases

Who this might be right for
IchthyosisPalmoplantar KeratosesEpidermolysis Bullosa+7 more
Maastricht University Medical Center 650
Not applicableStudy completedNCT00001813
What this trial is testing

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

Who this might be right for
Cockayne SyndromeSkin NeoplasmsXeroderma Pigmentosum+2 more
National Cancer Institute (NCI) 709
Not applicableStudy completedNCT03445052
What this trial is testing

XPAND Trial: Enhancing XP Photoprotection Activities - New Directions

Who this might be right for
Xeroderma Pigmentosum
Guy's and St Thomas' NHS Foundation Trust 15
Testing effectiveness (Phase 2)Ended earlyNCT01282047
What this trial is testing

Lenalidomide in Kaposi Disease Associated With HIV Infection

Who this might be right for
HIV Infection Associated Kaposi Disease
French National Agency for Research on AIDS and Viral Hepatitis 12
Not applicableStudy completedNCT00046189
What this trial is testing

Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum

Who this might be right for
Xeroderma PigmentosumBasal Cell CarcinomaSquamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 301
Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05159752
What this trial is testing

Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

Who this might be right for
Xeroderma Pigmentosum
Clinuvel Europe Limited 6
Not applicableLooking for participantsNCT05484570
What this trial is testing

Natural History Study for DNA Repair Disorders

Who this might be right for
DNA Repair DisorderCockayne SyndromeXeroderma Pigmentosum+1 more
University of Minnesota 40
Not applicableUnknownNCT03662828
What this trial is testing

Epidemiological Description of the Kaposi's Disease in France's Southeast

Who this might be right for
Kaposi's Disease
Direction Centrale du Service de Santé des Armées 100
Testing effectiveness (Phase 2)Ended earlyNCT04155190
What this trial is testing

Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Who this might be right for
Recurrent Basal Cell Carcinoma
Sol-Gel Technologies, Ltd. 47
Not applicableUnknownNCT01123694
What this trial is testing

Xeroderma Pigmentosum Patient Experiences

Who this might be right for
Xeroderma Pigmentosum
Henry Ford Health System 15
Testing effectiveness (Phase 2)Looking for participantsNCT05071222
What this trial is testing

Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE)

Who this might be right for
Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
Assistance Publique - Hôpitaux de Paris 5
Not applicableStudy completedNCT00555633
What this trial is testing

Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients

Who this might be right for
Skin CancerXeroderma PigmentosumBasal Cell Nevus Syndrome
Medical University of Graz 13
Testing effectiveness (Phase 2)UnknownNCT05370235
What this trial is testing

Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

Who this might be right for
Xeroderma Pigmentosum
Clinuvel Europe Limited 6